Clinical Trial of Breast Implants Indianapolis Carmel Indiana
Turkle & Associates is pleased to announce that Dr. Janet K. Turkle is one of a limited number of plastic surgeons in the U.S. now enrolling patients in a clinical trial of breast implants in Indianapolis and Carmel Indiana. The implant is the Inamed 410 Cohesive Gel Breast Implant.
The FDA has approved enrollment of additional breast implant patients in the clinical research study over the next six months. The clinical trials are open to patients seeking a first time breast augmentation, breast reconstruction and revision.
Eligibility for these breast implants, sometimes called “gummy bear” breast implants, can only be determined after an in-person consultation.
Although cohesive gel breast implants have been widely used in Europe since 1994, the FDA requires a large-scale clinical study be conducted in the United States before giving these implants final approval.
Instead of the implants being filled with saline or a liquid silicone gel, the 410 cohesive gel breast implants are filled with a cohesive silicone that is described as a “soft solid”. Therefore, one of the main advantages of the breast implants is that they seem to retain their shape.
Although this is a clinical study, the usual breast augmentation charges apply. All costs, including the services of the surgeon and the cost of the implants, are the responsibility of the patients participating in the study.
Turkle & Associates provides a variety of saline and silicone breast implants for the patient not interested in considering a cohesive gel breast implant.
If you would like to learn more about our clinical study of Cohesive Gel breast Implants at our Indianapolis practice, please click here to contact Turkle & Associates today.